| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/17/2000 | CN1052482C Camptothecin derivatives, preparations thereof and antitumor agents |
| 05/17/2000 | CN1052412C Cancer therapy injection and its preparing process |
| 05/17/2000 | CN1052408C Chinese herbal medicine composition and its preparing process |
| 05/17/2000 | CN1052405C Sophoridine use |
| 05/16/2000 | US6064720 Magnetic support for removable antiscatter grid |
| 05/16/2000 | US6063923 Cyclization of 4-ethyl-4-hydroxy-7-(7-iodo-9-(4-methyl piperazin-1-ylmethyl)-2,3-dihydro-(1,4)dioxino(2,3-g)quinolin -8-ylmethyl)-4,7-dihydro-1h-pyrano(3,4-c)pyridine-3,8-dione, resolving mixture to yield desired enantiomer |
| 05/16/2000 | US6063911 Methods and compositions for treatment of cell proliferative disorders |
| 05/16/2000 | US6063900 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof |
| 05/16/2000 | US6063818 Ethers or alkoxy and amide derivatives |
| 05/16/2000 | US6063814 Antileukemia agents and anticarcinogenic agents |
| 05/16/2000 | US6063812 Angiogenesis inhibitors, antiarthritic agents and anticarcinogenic agents plus synthesis |
| 05/16/2000 | US6063801 Heterocyclic topoisomerase poisons |
| 05/16/2000 | US6063796 Heterocyclic compounds of piperidine |
| 05/16/2000 | US6063787 Methods for the treatment of psoriasis and genital warts |
| 05/16/2000 | US6063780 Method of treating a tumor |
| 05/16/2000 | US6063596 G-protein coupled receptors associated with immune response |
| 05/16/2000 | US6063594 DNA encoding a novel human anion channel |
| 05/16/2000 | US6063586 Diagnostic protocol |
| 05/16/2000 | US6063585 Tumor necrosis factor receptor associated factor regulated protein product; for the prevention of tumors cause by epstein barr virus; antitumor agents |
| 05/16/2000 | US6063379 Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotypic monoclonal antibodies |
| 05/16/2000 | US6063375 Semiallogeneic cell hybrids and related methods for treating cancer |
| 05/16/2000 | CA2136226C Use of 2-halo adenine derivatives as therapeutic agents against chronic myelogenous leukemia |
| 05/16/2000 | CA2131826C Mn gene and protein |
| 05/16/2000 | CA2129288C Phosphonooxymethyl esters of taxane derivatives |
| 05/16/2000 | CA2097820C Proteoglycan(g009) effective in enhancing antitumor immunity |
| 05/16/2000 | CA1340994C Treatment of conditions and disease |
| 05/12/2000 | CA2288680A1 Modulation of cell proliferative disorders by cyclic rgd |
| 05/11/2000 | WO2000026407A1 Method for determining cancer by determining expression of mage-10 |
| 05/11/2000 | WO2000026395A2 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 05/11/2000 | WO2000026394A1 Variants of humanized anti-carcinoma monoclonal antibody cc49 |
| 05/11/2000 | WO2000026379A2 Polypeptide mediating cell permeability |
| 05/11/2000 | WO2000026372A1 Myosin heavy chain homolog |
| 05/11/2000 | WO2000026370A2 Adenine nucleotide translocator (ant) fusion proteins and uses thereof |
| 05/11/2000 | WO2000026360A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | WO2000026353A1 Cyclic peptide ligands that target urokinase plasminogen activator receptor, their pharmaceutical compositions and use |
| 05/11/2000 | WO2000026348A2 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 05/11/2000 | WO2000026347A1 Methods for the production of tcr gamma delta t cells |
| 05/11/2000 | WO2000026250A1 HUMAN H37 PROTEINS AND cDNAS ENCODING THE SAME |
| 05/11/2000 | WO2000026249A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | WO2000026247A2 Ikaros isoforms and mutants |
| 05/11/2000 | WO2000026245A2 Human membrane transport proteins |
| 05/11/2000 | WO2000026243A2 Transmembrane 4 proteins |
| 05/11/2000 | WO2000026236A2 Method of modulating cell differentiation or neoplastic transformation by altering cadherin-11 expression or function |
| 05/11/2000 | WO2000026216A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 05/11/2000 | WO2000026212A1 Chromenone and chromanone derivatives as integrin inhibitors |
| 05/11/2000 | WO2000026208A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity |
| 05/11/2000 | WO2000026206A1 Method for producing luteolin and luteolin derivatives |
| 05/11/2000 | WO2000026203A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/11/2000 | WO2000026202A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/11/2000 | WO2000026201A1 Benzoylpyridazines |
| 05/11/2000 | WO2000026197A1 Novel inhibitors of impdh enzyme |
| 05/11/2000 | WO2000026192A1 Substituted 2-phenylbenzimidazoles, the production thereof and their use |
| 05/11/2000 | WO2000026167A1 Vitamin d analogues |
| 05/11/2000 | WO2000025841A1 Implant with cavities containing therapeutic agents |
| 05/11/2000 | WO2000025829A2 Radiodense compositions |
| 05/11/2000 | WO2000025827A2 Dna molecules encoding muc-1 and use thereof in tumor vaccination |
| 05/11/2000 | WO2000025819A1 Enhanced radiation therapy |
| 05/11/2000 | WO2000025817A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 05/11/2000 | WO2000025813A1 CANCER IMMUNOTHERAPHY AND DIAGNOSIS USING UNIVERSAL TUMOR ASSOCIATED ANTIGENS, INCLUDING hTERT |
| 05/11/2000 | WO2000025808A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists |
| 05/11/2000 | WO2000025802A1 Pharmaceutical composition having antitumor activity and process for the preparation thereof |
| 05/11/2000 | WO2000025797A1 Combination therapy to treat hepatitis b virus |
| 05/11/2000 | WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines |
| 05/11/2000 | WO2000025788A1 Inhibitors of prenyl-protein transferase |
| 05/11/2000 | WO2000025780A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme |
| 05/11/2000 | WO2000025777A1 SUBSTITUTED PHENETHYLSULFONES AND METHOD OF REDUCING TNFαLEVELS |
| 05/11/2000 | WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 05/11/2000 | WO2000025775A1 Water-miscible pharmaceutical compositions of paclitaxel |
| 05/11/2000 | WO2000025774A1 Benzamide potassium channel inhibitors |
| 05/11/2000 | WO2000025770A1 Carbocyclic potassium channel inhibitors |
| 05/11/2000 | WO2000025763A2 Agents containing phenol derivatives having an inhibiting effect on the proliferation of tumour cells |
| 05/11/2000 | WO2000025758A1 Oral administration of adenosine analogs |
| 05/11/2000 | WO2000025725A2 Functional antagonists of hedgehog activity |
| 05/11/2000 | WO2000025665A1 Method for improved imaging and photodynamic therapy |
| 05/11/2000 | WO2000012710A8 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 05/11/2000 | WO2000009691A3 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 05/11/2000 | WO2000009150A3 Cytokine and cytokine receptor, agonist, antagonist and/or antibody combination for therapeutic use |
| 05/11/2000 | WO2000008158A3 Molecules designated ldcam |
| 05/11/2000 | WO2000007581A3 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 05/11/2000 | WO2000007543A3 Conjugates targeted to the interleukin-2 receptors |
| 05/11/2000 | WO1999060984A3 Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases |
| 05/11/2000 | WO1999054460A3 Human nucleic acid sequences of normal bladder tissue |
| 05/11/2000 | WO1999053036A3 Ste20-related protein kinases |
| 05/11/2000 | DE19910188A1 Implant, especially a stent, comprises a support at least partly covered with a layer of metal oxide and/or ceramic material to inhibit excessive cell growth |
| 05/11/2000 | DE19855421A1 Implant, especially a stent, having surface cavities containing a radioactive material to inhibit excessive cell growth |
| 05/11/2000 | DE19851184A1 N-Arylsulfonyl-aminosäure-omega-amide N-arylsulfonyl-amino-omega-amides |
| 05/11/2000 | DE19850701A1 Benzoylpyridazine Benzoylpyridazine |
| 05/11/2000 | DE19847364C1 Tumor-Protein Tumor protein |
| 05/11/2000 | CA2773380A1 Immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 05/11/2000 | CA2349818A1 Membrane transport proteins |
| 05/11/2000 | CA2349622A1 Heparanase activity neutralizing anti-heparanase monoclonal antibody |
| 05/11/2000 | CA2349567A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors |
| 05/11/2000 | CA2349444A1 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 05/11/2000 | CA2349417A1 Ikaros isoforms and mutants |
| 05/11/2000 | CA2349232A1 Benzoylpyridazines |
| 05/11/2000 | CA2349212A1 Myosin heavy chain homolog |
| 05/11/2000 | CA2349158A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | CA2348745A1 Dna molecules encoding muc-1 and use thereof in tumor vaccination |
| 05/11/2000 | CA2348703A1 Inhibitors of prenyl-protein transferase |
| 05/11/2000 | CA2348536A1 Radiodense compositions |